<DOC>
	<DOCNO>NCT01144910</DOCNO>
	<brief_summary>The aim investigator´s clinical trial investigate 52 patient age three five year viral-induced asthma 52 patient age three five year allergic asthma . Over time-span 5 year investigator explore lung function bronchial responsiveness . The investigator plan evaluate long-term clinical history moderate severe bronchial hyperresponsiveness preschool child asthma . Therefore factor like atopy child , parental atopy bronchial hyperresponsiveness explore .</brief_summary>
	<brief_title>The Long-term Prognosis Moderate Severe Bronchial Hyperresponsiveness ( BHR ) Asthmatic Preschool Children</brief_title>
	<detailed_description>A positive family history prevalence atopy , eczema , wheeze well-known factor predict asthma . Caudri et al . find important predictor like perinatal transmission , parental use inhalative medication wheezing/dyspnea viral infection ( 5 ) . Measurement BHR child study second outcome parameter . Four visit perform , baseline 1 , 3 , 5 year . At visit 1 investigator characterize patient ISAAC survey . At visit child methacholine challenge , skin Prick test , eNO , RAST total IgE perform . At visit 3 4 sputum induce . In parent first visit methacholine challenge perform . A genetic identification ADAM33 gene EDTA blood shall provide . ADAMs multidomain protein metalloprotease domain , associate airway remodelling . Visits keep time interval without asthma therapy respiratory infection . To examine feasibility methacholine challenge preschool child data measure 2006 analyse .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Bronchial Hyperreactivity</mesh_term>
	<mesh_term>Methacholine Chloride</mesh_term>
	<criteria>inform consent age 3 6 year diagnosis asthma pulmonary function : FEV1 ( % pred . ) ≥ 70 % ability carry 2 reproducible flow volume loop moderate severe BHR ( PD20 FEV1 ≤ 0,3 mg methacholine ) 4 week interval since last infection 8 hour washout period Short Acting Beta Agonist 1 week washout period Ipratropium Bromide 1 week washout period Long Acting Beta Agonist 4 week washout period Systemic Corticosteroids 4 week washout period Leukotriene Antagonists Age &lt; 3 &gt; 6 Years Pulmonary function test : FEV1 ( % pred . ) &lt; 70 % Others chronic disease infection ( e.g. , HIV , tuberculosis , malignancy ) Incapability perform spirometry Current participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>asthma</keyword>
	<keyword>preschool child</keyword>
	<keyword>bronchial hyperresponsiveness</keyword>
	<keyword>methacholine challenge test</keyword>
	<keyword>atopy</keyword>
</DOC>